Novartis AG
Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof

Abstract:

Provided herein are formulations, processes, solid forms and methods of use relating to (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-- ethylbenzyl)azetidine-3-carboxylic acid.